Oncovir, Inc is a pharmaceutical corporation dedicated to the development of nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders.
We promote Hiltonol® (poly-ICLC) as an experimental viral mimic and broad activator of innate and adaptive immunity. While initially developed as an interferon inducer, Hiltonol® has much broader biological effects in humans, including specific antiviral, immune activating, vaccine adjuvant, and antitumor actions.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 3203 Cleveland Ave Nw, Washington,dc 20008,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- oncovir.com
- Keywords
- immunotherapy.
- HQ
- Washington, DC
Oncovir, Inc. Questions
Oncovir, Inc.'s website is oncovir.com
Oncovir, Inc.'s LinkedIn profile is https://www.linkedin.com/company/oncovir
Oncovir, Inc. has
5 employees.
View email and phone details for 5
employees at Oncovir, Inc..
Oncovir, Inc.'s industry is
Pharmaceutical Manufacturing
Oncovir, Inc.'s top competitors are
Regenxbio,
Sapiensbio, Inc.,
Cyrus Scientific,
Ned Biosystems, Inc.,
Talent X,
Neogentc,
Xenthera, Inc.,
Rithem Life Sciences,
Mindchamps,
Therapex Co., Ltd.
Oncovir, Inc.'s categories are Pharmaceutical Manufacturing
Oncovir, Inc.'s founding year is 1998
